Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH

Mollerhoj, MB; Veidal, SS; Thrane, KT; Oro, D; Overgaard, A; Salinas, CG; Madsen, MR; Pfisterer, L; Vyberg, M; Simon, E; Broermann, A; Vrang, N; Jelsing, J; Feigh, M; Hansen, HH

Hansen, HH (通讯作者),Gubra, Horsholm Kongevej 11B, DK-2970 Horsholm, Denmark.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022; 15 (5): 1167

Abstract

Non-alcoholic steatohepatitis (NASH) has emerged as a major challenge for public health because of high global prevalence and lack of evidence-based t......

Full Text Link